Programme

Overview: This session will explore strategies to optimise treatment for early breast cancer, pushing the boundaries of current practices. It will highlight how advanced radiotherapy techniques are reducing cardiac risk, improving patient care, and minimising side effects. The use of biomarkers will be discussed, focusing on their potential to personalise treatment and enhance patient outcomes. The session will also review the role of tumour-bed boost, exploring how to identify patients who will benefit most and when it can be safely omitted. Finally, this session will explore the emerging role of artificial intelligence in treatment planning and delivery for early breast cancer.

Overview: Proffered Papers are presented in one of the sessions scheduled in the main session halls. Each author will present orally for 7 minutes, followed by 3 minutes for discussion. Sessions will be recorded and available on-demand.

Overview: Radiotherapy has been the focus of many de-escalation trials in oncology. This session gives a critical overview over de-escalation and radiotherapy omission trials as well as the specifics of trial design in this setting, in particular non-inferiority trials. The optimization for future design of trials in this space in regards of patient-relevant endpoints, non-inferiority margins and multi-disciplinary collaboration will be addressed.

Overview: Proffered Papers are presented in one of the sessions scheduled in the main session halls. Each author will present orally for 7 minutes, followed by 3 minutes for discussion. Sessions will be recorded and available on-demand.